Literature DB >> 6534106

Heterogeneous oxygenation of rectal carcinomas in humans: a critical parameter for preoperative irradiation?

P Wendling, R Manz, G Thews, P Vaupel.   

Abstract

Tissue oxygenation was measured in 10 patients with differentiated adenocarcinoma in a very localized region in the middle part of the rectum (grade I - II, clinical stage II) by means of a cryophotometric micromethod. The results obtained clearly show that the oxygenation of differentiated rectal adenocarcinoma is distinctly lower than that of the normal rectal mucosa; tissue hypoxia or even anoxia are a common feature in those tumors; There exist considerable inter- individual differences among tumors of the same clinical staging and histological grading; substantial intra- individual heterogeneities in the oxygenation are evident within the same tumor and even within neighbouring microareas of the tissue. These findings imply that the commonly used classifications do not allow any conclusions concerning the oxygenation status, and probably the radiosensitivity of a tumor, respectively.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6534106     DOI: 10.1007/978-1-4684-4895-5_28

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  14 in total

1.  Percolation and binding of monoclonal antibody BW494 to pancreatic carcinoma tissues during high dose immunotherapy and consequences for future therapy modalities.

Authors:  K Bosslet; H C Keweloh; P Hermentin; K H Muhrer; H H Sedlacek; G Schulz
Journal:  Br J Cancer Suppl       Date:  1990-07

2.  Identifying and targeting hypoxia in head and neck cancer: a brief overview of current approaches.

Authors:  Quynh-Thu Le
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007       Impact factor: 7.038

3.  Focal dose escalation using FDG-PET-guided intensity-modulated radiation therapy boost for postoperative local recurrent rectal cancer: a planning study with comparison of DVH and NTCP.

Authors:  Keiichi Jingu; Hisanori Ariga; Tomohiro Kaneta; Yoshihiro Takai; Ken Takeda; Lindel Katja; Kakutaro Narazaki; Takahiro Metoki; Keisuke Fujimoto; Rei Umezawa; Yoshihiro Ogawa; Kenji Nemoto; Masashi Koto; Masatoshi Mitsuya; Naruhiro Matsufuji; Shoki Takahashi; Shogo Yamada
Journal:  BMC Cancer       Date:  2010-04-07       Impact factor: 4.430

4.  Intra- and intertumor heterogeneities in total, chronic, and acute hypoxia in xenografted squamous cell carcinomas. Detection and quantification using (immuno-)fluorescence techniques.

Authors:  C-A Maftei; C Bayer; K Shi; P Vaupel
Journal:  Strahlenther Onkol       Date:  2012-06-14       Impact factor: 3.621

5.  Quantitative optical spectroscopy: a robust tool for direct measurement of breast cancer vascular oxygenation and total hemoglobin content in vivo.

Authors:  J Quincy Brown; Lee G Wilke; Joseph Geradts; Stephanie A Kennedy; Gregory M Palmer; Nirmala Ramanujam
Journal:  Cancer Res       Date:  2009-03-17       Impact factor: 12.701

Review 6.  Radiation treatment for rectal cancer.

Authors:  B J Cummings
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

Review 7.  Clinical biomarkers for hypoxia targeting.

Authors:  Quynh-Thu Le; Don Courter
Journal:  Cancer Metastasis Rev       Date:  2008-09       Impact factor: 9.264

Review 8.  New developments in radiation therapy for head and neck cancer: intensity-modulated radiation therapy and hypoxia targeting.

Authors:  Nancy Y Lee; Quynh-Thu Le
Journal:  Semin Oncol       Date:  2008-06       Impact factor: 4.929

9.  Aminolaevulinic acid-induced photodynamic therapy: cellular responses to glucose starvation.

Authors:  L Wyld; M Tomlinson; M W R Reed; N J Brown
Journal:  Br J Cancer       Date:  2002-04-22       Impact factor: 7.640

10.  Intracapillary HbO2 saturations in murine tumours and human tumour xenografts measured by cryospectrophotometry: relationship to tumour volume, tumour pH and fraction of radiobiologically hypoxic cells.

Authors:  E K Rofstad; B M Fenton; R M Sutherland
Journal:  Br J Cancer       Date:  1988-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.